non-surgical treatments for sagging jawline after weight loss glp-1 Fix Ozempic Face with Sculptra In early 2025, the AAFPRS

A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered

Theres also the issue most people are never told about: A significant part of the weight lost can be lean mass

The Landscape Of GLP-1 Receptor Agonists In Diabetes And Obesity Treatment By Nasim Pourarian and Kamran Zamanian, Ph.D

[DOI] [PubMed] [Google Scholar] 116.Baartscheer A., Schumacher C.A., van Borren M.M.G.J., Belterman C.N.W., Coronel R., Fiolet J.W.T

These drugs mimic the action of naturally occurring GLP-1, a hormone produced in the intestines in response to food intake

Glucagon-like peptide-1 receptor agonist use is associated with increased rates of acne vulgaris diagnosis in nondiabetic obese women but not men: a retrospective cohort study